Name: Study: Pfizer-BioNTech vaccine just as effective against viral variant
Brand: upi.com
SKU: upi-com-924
Availability: OnlineOnly

critic

Study: Pfizer-BioNTech vaccine just as effective against viral variant

preview

TrendingAdvertisementA medical worker is inoculated with the Moderna COVID-19 vaccine at a site in Los Angeles on Thursday. Photo by Jim Ruymen/UPI |The vaccine made by Pfizer and BioNTech may be effective against new variants of the coronavirus that have emerged in Britain and South Africa, a new study indicates.The , conducted by University of Texas researchers and supported by the companies, found that the Pfizer-BioNTech "BNT162b2" vaccine was no less effective against the variant viruses than the original.AdvertisementIt determined that antibodies in vaccinated subjects were just as able to neutralize a lab-created version of the mutated coronavirus.The findings were posted online and have yet to be peer-reviewed, but they offered hope that the approved "messenger RNA" COVID-19 vaccines approved so far will also work to neutralize the variant versions of the SARS-CoV-2 coronavirus."I think this [study] is really important, because there is a lot of fear and uncertainty at the moment about this specific question," La Jolla Institute for Immunology scientist Shane Crotty The Washington Post.One of the new variants, known as SARS-CoV-2 B.1.1.7, was first in Britain last month and since been detected in numerous countries around the world, including the United States and Canada.AdvertisementAnother variant also emerged independently in South Africa and has since been detected outside of the country.The Centers for Disease Control and Prevention says scientists are "working to learn more about these variants to better understand how easily they might be transmitted and whether currently authorized vaccines will protect people against them."Preliminary studies indicate the British variant is associated with increased transmissibility, but there is no evidence so far that they cause more severe illness or increased risk of death.Pfizer and Moderna -- maker of the other approved mRNA vaccine against COVID-19 -- each have said they believe their products will protect against the mutated forms of the virus.AdvertisementAdvertisementAdvertisement

TrendingAdvertisementA medical worker is inoculated with the Moderna COVID-19 vaccine at a site in Los Angeles on Thursday. Photo by Jim Ruymen/UPI |The vaccine made by Pfizer and BioNTech may be effective against new variants of the coronavirus that have emerged in Britain and South Africa, a new study indicates.The , conducted by University of Texas researchers and supported by the companies, found that the Pfizer-BioNTech "BNT162b2" vaccine was no less effective against the variant viruses than the original.AdvertisementIt determined that antibodies in vaccinated subjects were just as...

public

Don Jacobson

upi.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Study: Pfizer-BioNTech vaccine just as effective against viral variant

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS